Document is current
Any future updates will be listed below
-
Authors
Nadal-Bufí, Ferran
Chan, Lai Y.
Mohammad, Hadi H.
Mason, Jody M.
Salomon, Carlos
Lai, Andrew
Thompson, Erik W.
Craik, David J.
Kaas, Quentin
Henriques, Sónia T. https://orcid.org/0000-0001-9564-9651
-
Funding
Funding for this research was provided by:
Australian Research Council (FT150100398)
Australian Research Council (FL150100146)
Australian Research Council (CE200100012)
Australian Research Council (CE200100012)
Queensland University of Technology (Postgraduate Research Award Scholarship)
Biotechnology and Biological Sciences Research Council (BB/T018275/1)
Biotechnology and Biological Sciences Research Council (BB/R017956/1)
Cancer Research UK (A26941)
The Lion Medical Research Foundation (2015001964)
The Medical Research Future Fund (MRF1199984)
National Health and Medical Research Council (1195451)
The Donald & Joan Wilson Foundation Ltd (2020000323)
Ovarian Cancer Research Foundation (2018001167)
- License Information
-
More Information
Article History
Received: 27 September 2022
Revised: 9 November 2022
Accepted: 14 November 2022
First Online: 27 November 2022
Declarations
:
: The authors declare no conflicts or competing interests.
: Human red blood cells used in haemolytic assay were collected from adult healthy donors following protocols approved by the Human Research Ethics Committees at the University of Queensland (2013000582). Results are independent of blood donors, and their identity is not reported.
: Human donors consented the use of their blood for research purposes. Human donors consented publication of results using their blood.
: All the authors have read and approved the final version of the manuscript and agreed to its publication in Cellular and Molecular Life Sciences.
